Evidence map›Paper›PMID 25774152›Full record

ArticleFrontiers in microbiology2015

In vitro adhesion properties of Shiga toxin-producing Escherichia coli isolated from cattle, food, and humans.

Nathalie Pradel, Lucie Etienne-Mesmin, Jonathan Thévenot, Charlotte Cordonnier, Stéphanie Blanquet-Diot, Valérie Livrelli

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A Negative Regulator of Cellulose Biosynthesis,Frontiers in microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Nathalie PradelCentre de Recherche en Nutrition Humaine Auvergne, M2iSH, 'Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte' UMR INSERM/Université d'Auvergne U1071 USC-INRA 2018, Clermont Université - Université d'Auvergne Clermont-Ferrand, France.
Lucie Etienne-MesminCentre de Recherche en Nutrition Humaine Auvergne, M2iSH, 'Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte' UMR INSERM/Université d'Auvergne U1071 USC-INRA 2018, Clermont Université - Université d'Auvergne Clermont-Ferrand, France ; Centre de Recherche en Nutrition Humaine Auvergne, EA-4678 CIDAM, 'Conception Ingénierie et Développement de l'Aliment et du Médicament', Clermont Université - Université d'Auvergne Clermont-Ferrand, France.
Jonathan ThévenotCentre de Recherche en Nutrition Humaine Auvergne, M2iSH, 'Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte' UMR INSERM/Université d'Auvergne U1071 USC-INRA 2018, Clermont Université - Université d'Auvergne Clermont-Ferrand, France ; Centre de Recherche en Nutrition Humaine Auvergne, EA-4678 CIDAM, 'Conception Ingénierie et Développement de l'Aliment et du Médicament', Clermont Université - Université d'Auvergne Clermont-Ferrand, France.
Charlotte CordonnierCentre de Recherche en Nutrition Humaine Auvergne, M2iSH, 'Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte' UMR INSERM/Université d'Auvergne U1071 USC-INRA 2018, Clermont Université - Université d'Auvergne Clermont-Ferrand, France ; Centre de Recherche en Nutrition Humaine Auvergne, EA-4678 CIDAM, 'Conception Ingénierie et Développement de l'Aliment et du Médicament', Clermont Université - Université d'Auvergne Clermont-Ferrand, France.
Stéphanie Blanquet-DiotCentre de Recherche en Nutrition Humaine Auvergne, EA-4678 CIDAM, 'Conception Ingénierie et Développement de l'Aliment et du Médicament', Clermont Université - Université d'Auvergne Clermont-Ferrand, France.
Valérie LivrelliCentre de Recherche en Nutrition Humaine Auvergne, M2iSH, 'Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte' UMR INSERM/Université d'Auvergne U1071 USC-INRA 2018, Clermont Université - Université d'Auvergne Clermont-Ferrand, France ; Unité de Recherche M2iSH, Faculté de Pharmacie, CHU Clermont-Ferrand, Service Bactériologie Mycologie Parasitologie Clermont-Ferrand, France.
Centre de Recherche en Nutrition Humaine Rhône-Alpes · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRGenetique Reproduction and Developpement · FRUniversité Clermont Auvergne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shiga toxin-producing Escherichia coli (STEC) are able to cause serious illnesses ranging from diarrhea to hemorrhagic colitis and hemolytic-uremic syndrome (HUS). These bacteria colonize the digestive tract of humans and produce Shiga-toxins, which are considered to be essential for virulence and are crucial in lethal infection. Colon colonization is supposed to be a determinant step in the development of the infection, but the virulence traits that mediate this step are unclear. We analyzed the ability of 256 STEC strains belonging to seropathotype A (the most virulent O157:H7 serotype) to seropathotype E (not involved in human disease) to adhere to HEp-2, HCT-8, and T84 cell lines. Of the 256 STEC tested most (82%) were non-adherent in our assays. The adhesion levels were globally low and were not related to pathogenicity, although the highest levels were associated to O26:H11 and O103:H2 strains of seropathotype B (associated with HUS but less commonly than serotype O157:H7), possessing both the eae and toxB genes.

Indexed as

cell lines adhesioneaeseropathotypeSTECtoxB

Identifiers

PMID25774152
PMCPMC4343011
OpenAlexW2037172973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.